Xtl Biopharmaceuticals (XTLB) EBITDA Margin Growth (1y) (2012 - 2018)
Xtl Biopharmaceuticals (XTLB) EBITDA Margin Growth (1y) (2012 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -8,064.00 |
| Jun 30, 2018 | 46,214.00 |
| Mar 31, 2018 | 5,610.00 |
| Sep 30, 2014 | -30,314.00 |
| Jun 30, 2014 | 8,926.00 |
| Mar 31, 2014 | 23,834.00 |
| Dec 31, 2013 | 19,764.00 |
| Sep 30, 2013 | 22,337.00 |
| Jun 30, 2013 | -5,685.00 |
| Mar 31, 2013 | -16,521.00 |
| Dec 31, 2012 | -6,099.00 |
| Sep 30, 2012 | 6,626.00 |
| Jun 30, 2012 | -7,105.00 |